Cancer treatment names can be confusing, but knowing how your therapy works can help you feel more prepared. These short, plain-language videos explain common chemotherapy, immunotherapy, hormone therapy, and targeted therapy regimens. Each video reviews how the treatment is given, how often you receive it, side effects to watch for, and ways to stay safe and comfortable. All content is reviewed by oncology professionals to help you feel informed and confident throughout your treatment.

Treatment Regimen Videos

1. Aromatase Inhibitors
2. Bispecific Antibodies
3. CARBO-PEMETREXED
4. Carbo-Taxol
5. CAR-T Cell Therapy
6. CHOP
7. Cisplatin-Gemcitabine
8. DD AC-T
9. DVRd
10. Enhertu
11. FOLFIRINOX
12. FOLFOX
13. Immunotherapy
14. Keynote-522
15. Keytruda
16. Platinum Etoposide
17. Rituxan
18. TCHP

Aromatase Inhibitors Treatment

In this video, we cover:

  • The role of hormone therapy: Why lowering estrogen helps control estrogen receptor (ER)-positive breast cancer..

  • Your treatment schedule: Taken as a daily pill, often for 5 years or longer.

  • Managing common side effects: Joint stiffness, hot flashes, bone thinning, and fatigue

Back to Top
Site Survey

Bispecific Antibodies

This video explores one of the most exciting advancements in cancer therapy: bispecific antibodies. We'll break down how this powerful immunotherapy works as a "smart bridge," connecting your own immune cells directly to myeloma cells to launch a precise and powerful attack. Learn about this cutting-edge treatment and what it could mean for the future of myeloma care.

Back to Top
Site Survey

CARBO + PEMETREXED Treatment

In this video, we cover:

  • The role of combination chemotherapy: Why pairing two drugs helps target cancer more effectively.

  • Meet the components:

    • Carboplatin (Carbo): A platinum-based drug that damages cancer cell DNA.

    • Pemetrexed: Blocks building blocks cancer cells need to grow and divide.

  • Your treatment schedule: IV infusions, typically every 3 weeks in repeating cycles.

  • Managing common side effects: Fatigue, nausea, low blood counts, and infection risk — with vitamin supplementation (folic acid and B12) to reduce side effects.

Back to Top
Site Survey

In this video, we cover:

  • The role of combination chemotherapy: Why pairing two drugs can be more effective.

  • Meet the components:

    • Carboplatin (Carbo): A platinum-based drug that damages the DNA of cancer cells.

    • Paclitaxel (Taxol): A chemotherapy drug that disrupts the inner structure of cells, stopping them from dividing.

  • Your treatment schedule: How the drugs are given (typically every 3 weeks, or sometimes weekly) and what to expect during each cycle.

  • Managing common side effects: Discussion of fatigue, nausea, hair loss, and neuropathy — with tips on how your care team can help.

Carbo–Taxol Treatment

Back to Top
Site Survey

CAR-T Cell Therapy

Welcome to the forefront of cancer treatment. This video explains CAR-T Cell Therapy, a revolutionary immunotherapy that supercharges your own immune system to fight back against cancer. We'll walk you through this groundbreaking process, often called a "living drug," where your own T-cells are collected, re-engineered in a lab to recognize and attack cancer cells, and then returned to your body to do their job.

Back to Top
Site Survey

In this video, we cover:

  • The role of combination chemotherapy: How using multiple drugs targets cancer cells in different ways.

  • Meet the components:

    • Cyclophosphamide: Damages DNA to stop cancer growth.

    • Doxorubicin: Interferes with DNA inside rapidly dividing cells.

    • Vincristine: Blocks cells from dividing.

    • Prednisone: A steroid that fights cancer and reduces inflammation.

  • Your treatment schedule: IV chemotherapy given in cycles, plus oral prednisone tablets.

  • Managing common side effects: Hair loss, fatigue, nausea, lowered blood counts, and infection risk — with supportive medicines like growth factors and anti-nausea drugs.

CHOP Treatment

Back to Top
Site Survey

Cisplatin-Gemcitabine Treatment

In this video, we cover:

  • The role of combination chemotherapy: Why using two drugs together improves effectiveness by attacking cancer cells in different ways.

  • Meet the components:

    • Cisplatin: Damages cancer cell DNA, stopping them from dividing and growing.

    • Gemcitabine: A nucleoside analog that blocks DNA building, preventing cancer cells from repairing themselves.

  • Managing common side effects: Nausea, vomiting, fatigue, lowered blood counts, risk of infection, and kidney effects.

Back to Top
Site Survey

Dose-Dense AC→T Treatment

This video explains the ddAC→T treatment plan for breast cancer in a simple, clear way. We cover:

  • What ddAC→T is and why it’s used

  • Treatment schedule:

    • AC phase (Adriamycin + Cyclophosphamide) every 2 weeks × 4 cycles

    • Followed by T phase (Paclitaxel) weekly × 12 or every 2 weeks × 4

  • Tips for managing side effects and staying safe during treatment

Back to Top
Site Survey

DVRd Treatment

In this video, we cover:

  • The Power of Four: An introduction to combination therapy and why using four drugs together is so effective against multiple myeloma.

  • Meet the Components: A clear explanation of each drug in the regimen:

  • Your Treatment Schedule: A look at what to expect, including the cycles of infusions, injections, and oral medications.

  • Managing Common Side Effects: A practical discussion of potential side effects, such as fatigue and neuropathy, and how your care team will help manage them.

Back to Top
Site Survey

In this video, we cover:

  • The role of targeted therapy: How Enhertu combines the precision of antibody therapy with the power of chemotherapy.

  • Meet the components:

    • Trastuzumab: Targets HER2, a protein found on some breast, stomach, and lung cancers.

    • Deruxtecan (chemotherapy payload): Released inside cancer cells to kill them from within.

  • Your treatment schedule: Given by IV infusion, usually every 3 weeks in cycles.

  • Managing common side effects: Nausea, fatigue, low blood counts, hair loss, and a serious risk of lung inflammation (interstitial lung disease) — with urgent evaluation if cough or shortness of breath develop.

ENHERTU Treatment

Back to Top
Site Survey

FOLFIRINOX Treatment

This video explains the FOLFIRINOX treatment plan for pancreatic and other gastrointestinal cancers in a clear, simple way. We cover:

  • What FOLFIRINOX is: a combination of FOLinic acid (leucovorin), Fluorouracil (5-FU), IRINotecan, and OXaliplatin

  • How it’s given: every 2 weeks in cycles; treatment includes an infusion day followed by a home 5-FU pump for 46 hours

  • Tips for managing side effects and staying safe during treatment

Back to Top
Site Survey

FOLFOX Treatment

This video explains everything you need to know about FOLFOX chemotherapy in a simple, clear, and patient-friendly way. We cover:

  • What FOLFOX is and why it’s used to treat colorectal and other cancers

  • How it’s given — a combination of FOLinic acid (leucovorin), Fluorouracil (5-FU), and OXaliplatin

  • Treatment schedule — typically given every 2 weeks in cycles

  • What to expect on infusion day and how the home 5-FU pump works (if used)

  • Common side effects — neutropenia, nausea, diarrhea, fatigue, neuropathy, and taste changes

  • Tips for managing side effects and when to call your oncology team immediately

Back to Top
Site Survey

Immunotherapy Treatment

In this video we cover:

  • How immunotherapy works at the cellular level

  • Which cancers and patients may benefit

  • The role of biomarkers and tumor testing in determining eligibility

  • How the treatment is given (usually by IV infusion)

  • Common side effects, including immune-related inflammation

  • Long-term benefits like durable tumor control in some patients

The goal? To harness your own immune system to fight cancer — smarter, longer, and more precisely.

Back to Top
Site Survey

KEYNOTE-522: Triple-Negative Breast Cancer (TNBC) Treatment Protocol

This video explains the KEYNOTE-522 treatment plan for patients with triple-negative breast cancer (TNBC) in a clear and simple way. We cover:

  • Treatment plan:

    • Neoadjuvant therapy (before surgery):

      • Paclitaxel + Carboplatin + Pembrolizumab → weekly for 12 weeks

      • Followed by AC chemotherapy (Adriamycin + Cyclophosphamide) + Pembrolizumab → every 3 weeks × 4 cycles

    • Surgery

    • Adjuvant therapy (after surgery): Pembrolizumab continues for up to 9 cycles

  • Tips for managing side effects and staying on track during treatment

Back to Top
Site Survey

Pembrolizumab (Keytruda)

This video explains the Pembrolizumab (Keytruda) treatment plan

  • How it’s given: an IV infusion every 3 or 6 weeks, depending on your treatment plan

  • Common side effects: fatigue, cough, rash, diarrhea, nausea, and joint pain

  • Immune-related side effects: Keytruda can affect the lungs, liver, thyroid, colon, and other organs — report new or unusual symptoms immediately

  • Fever or signs of infection: Call your oncology team right away if your temperature is ≥100.4°F (38°C)

Back to Top
Site Survey

Platinum–Etoposide Treatment

In this video, we cover:

  • Why combination therapy matters: How using two drugs together can improve treatment results.

  • Meet the components:

    • Platinum (Cisplatin or Carboplatin): A chemotherapy drug that damages cancer cell DNA so the cells cannot grow or repair themselves.

    • Etoposide: A drug that stops cancer cells from dividing and multiplying.

  • Your treatment schedule: What to expect, including infusion cycles and timing.

  • Managing common side effects: Practical guidance on nausea, fatigue, and low blood counts — and how your care team helps you manage them.

Back to Top
Site Survey

Rituxan Treatment

This video explains everything you need to know about Rituxan treatment in a simple and clear way. We walk you through:

  • What Rituxan is and how it works to treat certain cancers and immune conditions

  • How it’s given — through an IV infusion or a subcutaneous injection called Rituxan Hycela

  • Treatment schedule and what to expect before, during, and after each dose

  • Common side effects and tips to manage them

Back to Top
Site Survey

TCHP Treatment

This video explains the TCHP treatment plan for HER2-positive breast cancer in a simple, clear way. We cover:

  • What TCHP is: a combination of Taxotere (docetaxel), Carboplatin, Herceptin (trastuzumab), and Perjeta (pertuzumab)

  • How it’s given: every 3 weeks × 6 cycles; Herceptin + Perjeta may be continued to complete 1 year of therapy

  • Phesgo option: Herceptin + Perjeta can also be given together as a single subcutaneous injection

  • Tips for managing side effects and staying safe during treatment

Back to Top
Site Survey